Unknown

Dataset Information

0

Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.


ABSTRACT: We have been investigating the role that phosphatidylethanolamine (PE) and phosphatidylcholine (PC) content plays in modulating the solubility of the Parkinson's disease protein alpha-synuclein (?-syn) using Saccharomyces cerevisiae and Caenorhabditis elegans. One enzyme that synthesizes PE is the conserved enzyme phosphatidylserine decarboxylase (Psd1/yeast; PSD-1/worms), which is lodged in the inner mitochondrial membrane. We previously found that decreasing the level of PE due to knockdown of Psd1/psd-1 affects the homeostasis of ?-syn in vivo. In S. cerevisiae, the co-occurrence of low PE and ?-syn in psd1? cells triggers mitochondrial defects, stress in the endoplasmic reticulum, misprocessing of glycosylphosphatidylinositol-anchored proteins, and a 3-fold increase in the level of ?-syn. The goal of this study was to identify drugs that rescue this phenotype. We screened the Prestwick library of 1121 Food and Drug Administration-approved drugs using psd1? + ?-syn cells and identified cyclosporin A, meclofenoxate hydrochloride, and sulfaphenazole as putative protective compounds. The protective activity of these drugs was corroborated using C. elegans in which ?-syn is expressed specifically in the dopaminergic neurons, with psd-1 depleted by RNAi. Worm populations were examined for dopaminergic neuron survival following psd-1 knockdown. Exposure to cyclosporine, meclofenoxate, and sulfaphenazole significantly enhanced survival at day 7 in ?-syn-expressing worm populations whereby 50-55% of the populations displayed normal neurons, compared to only 10-15% of untreated animals. We also found that all three drugs rescued worms expressing ?-syn in dopaminergic neurons that were deficient in the phospholipid cardiolipin following cardiolipin synthase (crls-1) depletion by RNAi. We discuss how these drugs might block ?-syn pathology in dopaminergic neurons.

SUBMITTER: Wang S 

PROVIDER: S-EPMC5063346 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.

Wang Shaoxiao S   Zhang Siyuan S   Xu Chuan C   Barron Addie A   Galiano Floyd F   Patel Dhaval D   Lee Yong Joo YJ   Caldwell Guy A GA   Caldwell Kim A KA   Witt Stephan N SN  

PloS one 20161013 10


We have been investigating the role that phosphatidylethanolamine (PE) and phosphatidylcholine (PC) content plays in modulating the solubility of the Parkinson's disease protein alpha-synuclein (α-syn) using Saccharomyces cerevisiae and Caenorhabditis elegans. One enzyme that synthesizes PE is the conserved enzyme phosphatidylserine decarboxylase (Psd1/yeast; PSD-1/worms), which is lodged in the inner mitochondrial membrane. We previously found that decreasing the level of PE due to knockdown of  ...[more]

Similar Datasets

| S-EPMC3292748 | biostudies-literature
| S-EPMC3899493 | biostudies-other
| S-EPMC5073045 | biostudies-literature
| S-EPMC2669752 | biostudies-literature
| S-EPMC5349099 | biostudies-literature
| S-EPMC3293148 | biostudies-literature
| S-EPMC2587621 | biostudies-literature
2024-07-11 | GSE271930 | GEO